Chondroitin sulfate proteoglycans: Structure-function relationship with implication in neural development and brain disorders

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Avram, Speranta ^a   Shaposhnikov, Sergey ^b   Buiu, Catalin ^a,c   Mernea, Maria ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b NorGenoTech AS   (Norway)

^c UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CHONDROITIN; CHONDROITIN ABC LYASE; GLYCOSYLTRANSFERASE; NERVE CELL ADHESION MOLECULE; NEUROCAN; PROTEOCHONDROITIN SULFATE; SULFOTRANSFERASE; VERSICAN;

ATTENTION DEFICIT DISORDER; BIOLOGICAL ACTIVITY; BIPOLAR DISORDER; BRAIN DISEASE; CELL ADHESION; CELL MIGRATION; CRYSTAL STRUCTURE; HEALTH STATUS; HIPPOCAMPAL CA1 REGION; HUMAN; MOLECULAR MODEL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; CENTRAL NERVOUS SYSTEM; CHEMISTRY; EXTRACELLULAR MATRIX; GENETICS; HUMAN GENOME; NERVE REGENERATION; PATHOLOGY; ULTRASTRUCTURE; X RAY CRYSTALLOGRAPHY;

BRAIN DISEASES; CENTRAL NERVOUS SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; CRYSTALLOGRAPHY, X-RAY; EXTRACELLULAR MATRIX; GENOME, HUMAN; HUMANS; NERVE REGENERATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901808522     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/642798     Document Type: Review

References (93)

1. Geissler M., Gottschling C., Aguado A., Rauch U., Wetzel C. H., Hatt H., Faissner A., Primary hippocampal neurons, which lack four crucial extracellular matrix molecules, display abnormalities of synaptic structure and function and severe deficits in perineuronal net formation. The Journal of Neuroscience 2013 33 18 7742 7755
2. Perea G., Navarrete M., Araque A., Tripartite synapses: astrocytes process and control synaptic information. Trends in Neurosciences 2009 32 8 421 431 2-s2.0-68049143450 10.1016/j.tins.2009.05.001
3. 2+ detection and modulation of synaptic release by astrocytes. Nature Neuroscience 2011 14 10 1276 1284 2-s2.0-80053258053 10.1038/nn.2929
4. Bekku Y., Oohashi T., Neurocan contributes to the molecular heterogeneity of the perinodal ECM. Archives of Histology and Cytology 2011 73 2 95 102 2-s2.0-79957954936 10.1679/aohc.73.95
5. Wiese S., Karus M., Faissner A., Astrocytes as a source for extracellular matrix molecules and cytokines. Frontiers in Pharmacology 2012 3 120
6. Bandtlow C. E., Zimmermann D. R., Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiological Reviews 2000 80 4 1267 1290 2-s2.0-0033778942
7. Yi J. H., Katagiri Y., Susarla B., Figge D., Symes A. J., Geller H. M., Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice. Journal of Comparative Neurology 2012 520 15 3295 3313
8. Jones L. L., Margolis R. U., Tuszynski M. H., The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Experimental Neurology 2003 182 2 399 411 2-s2.0-0042665641 10.1016/S0014-4886(03)00087-6 (Pubitemid 36937092)
9. Monnier P. P., Sierra A., Schwab J. M., Henke-Fahle S., Mueller B. K., The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Molecular and Cellular Neuroscience 2003 22 3 319 330 2-s2.0-0037356722 10.1016/S1044-7431(02) 00035-0 (Pubitemid 36407595)
10. Meyer-Puttlitz B., Milev P., Junker E., Zimmer I., Margolis R. U., Margolis R. K., Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan. Journal of Neurochemistry 1995 65 5 2327 2337 2-s2.0-0028865943
11. Dutt S., Cassoly E., Dours-Zimmermann M. T., Matasci M., Stoeckli E. T., Zimmermann D. R., Versican V0 and V1 direct the growth of peripheral axons in the developing chick hindlimb. Journal of Neuroscience 2011 31 14 5262 5270 2-s2.0-79955729899 10.1523/JNEUROSCI.4897-10.2011
12. Laabs T. L., Wang H., Katagiri Y., McCann T., Fawcett J. W., Geller H. M., Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans. Journal of Neuroscience 2007 27 52 14494 14501 2-s2.0-37549049803 10.1523/JNEUROSCI.2807- 07.2007
13. Bukhari N., Torres L., Robinson J. K., Tsirka S. E., Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system. Journal of Neuroscience 2011 31 42 14931 14943 2-s2.0-80054771099 10.1523/JNEUROSCI.3339-11.2011
14. Carulli D., Pizzorusso T., Kwok J. C. F., Putignano E., Poli A., Forostyak S., Andrews M. R., Deepa S. S., Glant T. T., Fawcett J. W., Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010 133 8 2331 2347 2-s2.0-77955148070 10.1093/brain/awq145
15. Wang D., Ichiyama R. M., Zhao R., Andrews M. R., Fawcett J. W., Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. Journal of Neuroscience 2011 31 25 9332 9344 2-s2.0-79959672790 10.1523/JNEUROSCI.0983-11.2011
16. Lee H. J., Bian S., Jakovcevski I., Wu B., Irintchev A., Schachner M., Delayed applications of L1 and chondroitinase ABC promote recovery after spinal cord injury. Journal of Neurotrauma 2012 29 10 1850 1863
17. Mühleisen T. W., Mattheisen M., Strohmaier J., Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophrenia Research 2012 138 1 69 73
18. Cichon S., Mühleisen T. W., Degenhardt F. A., Mattheisen M., Miró X., Strohmaier J., Steffens M., Meesters C., Herms S., Weingarten M., Priebe L., Haenisch B., Alexander M., Vollmer J., Breuer R., Schmäl C., Tessmann P., Moebus S., Wichmann H.-E., Schreiber S., Müller-Myhsok B., Lucae S., Jamain S., Leboyer M., Bellivier F., Etain B., Henry C., Kahn J.-P., Heath S., Hamshere M., O'Donovan M. C., Owen M. J., Craddock N., Schwarz M., Vedder H., Kammerer-Ciernioch J., Reif A., Sasse J., Bauer M., Hautzinger M., Wright A., Mitchell P. B., Schofield P. R., Montgomery G. W., Medland S. E., Gordon S. D., Martin N. G., Gustafsson O., Andreassen O., Djurovic S., Sigurdsson E., Steinberg S., Stefansson H., Stefansson K., Kapur-Pojskic L., Oruc L., Rivas F., Mayoral F., Chuchalin A., Babadjanova G., Tiganov A. S., Pantelejeva G., Abramova L. I., Grigoroiu-Serbanescu M., Diaconu C. C., Czerski P. M., Hauser J., Zimmer A., Lathrop M., Schulze T. G., Wienker T. F., Schumacher J., Maier W., Propping P., Rietschel M., Nöthen M. M., Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. American Journal of Human Genetics 2011 88 3 372 381
19. Oruc L., Kapur-Pojskic L., Ramic J., Pojskic N., Bajrovic K., Assessment of relatedness between neurocan gene as bipolar disorder susceptibility locus and schizophrenia. Bosnian Journal of Basic Medical Sciences 2012 12 4 245 248
20. Iseki K., Hagino S., Nikaido T., Zhang Y., Mori T., Yokoya S., Hozumi Y., Goto K., Wanaka A., Tase C., Gliosis-specific transcription factor OASIS coincides with proteoglycan core protein genes in the glial scar and inhibits neurite outgrowth. BioMed Research 2012 33 6 345 353
21. Kitagawa H., Uyama T., Sugahara K., Molecular cloning and expression of a human chondroitin synthase. The Journal of Biological Chemistry 2001 276 42 38721 38726 2-s2.0-0035914310 10.1074/jbc.M106871200
22. Kitagawa H., Izumikawa T., Uyama T., Sugahara K., Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. The Journal of Biological Chemistry 2003 278 26 23666 23671 2-s2.0-0037478786 10.1074/jbc.M302493200 (Pubitemid 36833253)
23. Izumikawa T., Koike T., Shiozawa S., Sugahara K., Tamura J.-I., Kitagawa H., Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. The Journal of Biological Chemistry 2008 283 17 11396 11406 2-s2.0-45549097559 10.1074/jbc.M707549200
24. Izumikawa T., Uyama T., Okuura Y., Sugahara K., Kitagawa H., Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor. Biochemical Journal 2007 403 3 545 552 2-s2.0-34247880268 10.1042/BJ20061876 (Pubitemid 46706983)
25. Mikami T., Kitagawa H., Biosynthesis and function of chondroitin sulfate. Biochim Biophys Acta 2013 1830 10 4719 4733
26. Hurtado A., Podinin H., Oudega M., Grimpe B., Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord. Brain 2008 131 10 2596 2605 2-s2.0-54949152772 10.1093/brain/awn206
27. Cua R. C., Lau L. W., Keough M. B., Midha R., Apte S. S., Yong V. W., Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. Glia 2013 61 6 972 984
28. Prange C. K., Pennacchio L. A., Lieuallen K., Fan W., Lennon G. G., Characterization of the human neurocan gene, CSPG3. Gene 1998 221 2 199 205 2-s2.0-0032561537 10.1016/S0378-1119(98)00455-7 (Pubitemid 29023747)
29. Zhou X.-H., Brakebusch C., Matthies H., Oohashi T., Hirsch E., Moser M., Krug M., Seidenbecher C. I., Boeckers T. M., Rauch U., Buettner R., Gundelfinger E. D., Fässler R., Neurocan is dispensable for brain development. Molecular and Cellular Biology 2001 21 17 5970 5978 2-s2.0-0034909716 10.1128/MCB.21.17.5970-5978.2001 (Pubitemid 32737813)
30. Rauch U., Clement A., Retzler C., Frohlich L., Fassler R., Gohring W., Faissner A., Mapping of a defined neurocan binding site to distinct domains of tenascin-C. The Journal of Biological Chemistry 1997 272 43 26905 26912 (Pubitemid 27452640)
31. Rauch U., Feng K., Zhou X.-H., Neurocan: a brain chondroitin sulfate proteoglycan. Cellular and Molecular Life Sciences 2001 58 12-13 1842 1856 2-s2.0-0035201906 (Pubitemid 33108773)
32. Retzler C., Gohring W., Rauch U., Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM. The Journal of Biological Chemistry 1996 271 44 27304 27310 (Pubitemid 26367284)
33. Geer L. Y., Marchler-Bauer A., Geer R. C., Han L., He J., He S., Liu C., Shi W., Bryant S. H., The NCBI BioSystems database. Nucleic Acids Research 2009 38 1 D492 D496 2-s2.0-75549088021 10.1093/nar/gkp858
34. Magrane M., Consortium U., UniProt Knowledgebase: a hub of integrated protein data. Database 2011 2011 bar009 2-s2.0-79960976768 10.1093/database/ bar009
35. Iozzo R. V., Murdoch A. D., Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. The FASEB Journal 1996 10 5 598 614 (Pubitemid 26141171)
36. Seyfried N. T., McVey G. F., Almond A., Mahoney D. J., Dudhia J., Day A. J., Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. The Journal of Biological Chemistry 2005 280 7 5435 5448 2-s2.0-14044272769 10.1074/jbc.M411297200 (Pubitemid 40280019)
37. Teriete P., Banerji S., Noble M., Blundell C. D., Wright A. J., Pickford A. R., Lowe E., Mahoney D. J., Tammi M. I., Kahmann J. D., Campbell I. D., Day A. J., Jackson D. G., Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Molecular Cell 2004 13 4 483 496 2-s2.0-10744221425 10.1016/S1097-2765(04)00080-2 (Pubitemid 38299377)
38. Wood-Charlson E. M., Weis V. M., The diversity of C-type lectins in the genome of a basal metazoan, Nematostella vectensis. Developmental and Comparative Immunology 2009 33 8 881 889 2-s2.0-67349256360 10.1016/j.dci.2009. 01.008
39. van Kooyk Y., C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochemical Society Transactions 2008 36 6 1478 1481 2-s2.0-59149106509 10.1042/BST0361478
40. Cardone M., Ikeda K. N., Varano B., Belardelli F., Millefiorini E., Gessani S., Conti L., Opposite regulatory effects of IFN-beta and IL-3 on C-type lectin receptors, antigen uptake, and phagocytosis in human macrophages. Journal of Leukocyte Biology 2014 95 1 161 168
41. Gijzen K., Cambi A., Torensma R., Figdor C. G., C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates. Current Protein and Peptide Science 2006 7 4 283 294 2-s2.0-33747245072 10.2174/138920306778018016
42. Pyka M., Wetzel C., Aguado A., Geissler M., Hatt H., Faissner A., Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons. European Journal of Neuroscience 2011 33 12 2187 2202 2-s2.0-80053920712 10.1111/j.1460-9568.2011.07690.x
43. Gasimli L., Stansfield H. E., Nairn A. V., Liu H., Paluh J. L., Yang B., Dordick J. S., Moremen K. W., Linhardt R. J., Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells. Glycoconjugate Journal 2013 30 5 497 510
44. Hoffman S., Sorkin B. C., White P. C., Brackenbury R., Mailhammer R., Rutishauser U., Cunningham B. A., Edelman G. M., Chemical characterization of a neural cell adhesion molecule purified from embryonic brain membranes. The Journal of Biological Chemistry 1982 257 13 7720 7729 2-s2.0-0020479284
45. Rao Y., Wu X.-F., Gariepy J., Rutishauser U., Siu C.-H., Identification of a peptide sequence involved in homophilic binding in the neural cell adhesion molecule NCAM. Journal of Cell Biology 1992 118 4 937 949 2-s2.0-0026670583
46. Kasper C., Rasmussen H., Kastrup J. S., Ikemizu S., Jones E. Y., Berezin V., Bock E., Larsen I. K., Structural basis of cell-cell adhesion by NCAM. Nature Structural Biology 2000 7 5 389 393 2-s2.0-0034103612 10.1038/75165 (Pubitemid 30250002)
47. Nybroe O., Moran N., Bock E., Equilibrium binding analysis of neural cell adhesion molecule binding to heparin. Journal of Neurochemistry 1989 52 6 1947 1949 2-s2.0-0024395344 (Pubitemid 19140789)
48. Horstkorte R., Schachner M., Magyar J. P., Vorherr T., Schmitz B., The fourth immunoglobulin-like domain of NCAM contains a carbohydrate recognition domain for oligomannosidic glycans implicated in association with L1 and neurite outgrowth. Journal of Cell Biology 1993 121 6 1409 1422 2-s2.0-0027243414 (Pubitemid 23174556)
49. Soroka V., Kolkova K., Kastrup J. S., Diederichs K., Breed J., Kiselyov V. V., Poulsen F. M., Larsen I. K., Welte W., Berezin V., Bock E., Kasper C., Structure and interactions of NCAM Ig1-2-3 suggest a novel zipper mechanism for homophilic adhesion. Structure 2003 11 10 1291 1301 2-s2.0-2342508857 10.1016/j.str.2003.09.006 (Pubitemid 37214890)
50. Kulahin N., Kristensen O., Rasmussen K. K., Olsen L., Rydberg P., Vestergaard B., Kastrup J. S., Berezin V., Bock E., Walmod P. S., Gajhede M., Structural model and trans-interaction of the entire ectodomain of the olfactory cell adhesion molecule. Structure 2011 19 2 203 211 2-s2.0-79551696709 10.1016/j.str.2010.12.014
51. Carafoli F., Saffell J. L., Hohenester E., Structure of the tandem fibronectin type 3 domains of neural cell adhesion molecule. Journal of Molecular Biology 2008 377 2 524 534 2-s2.0-40049086554 10.1016/j.jmb.2008.01. 030
52. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.
53. Schwartz N. B., Domowicz M., Proteoglycans in brain development. Glycoconjugate Journal 2004 21 6 329 341 2-s2.0-7244256103 10.1023/B:GLYC. 0000046278.34016.36 (Pubitemid 39434561)
54. Popp S., Maurel P., Andersen J. S., Margolis R. U., Developmental changes of aggrecan, versican and neurocan in the retina and optic nerve. Experimental Eye Research 2004 79 3 351 356 2-s2.0-4444356338 10.1016/j.exer.2004.05.016 (Pubitemid 39164472)
55. Morawski M., Brückner G., Arendt T., Matthews R. T., Aggrecan: beyond cartilage and into the brain. International Journal of Biochemistry and Cell Biology 2012 44 5 690 693 2-s2.0-84859270717 10.1016/j.biocel.2012.01.010
56. Aspberg A., The different roles of aggrecan interaction domains. Journal of Histochemistry & Cytochemistry 2012 60 12 987 996
57. Theocharis A. D., Skandalis S. S., Tzanakakis G. N., Karamanos N. K., Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS Journal 2010 277 19 3904 3923 2-s2.0-77956641177 10.1111/j.1742-4658.2010.07800.x
58. Wiedemann H., Paulsson M., Timpl R., Domain structure of cartilage proteoglycans revealed by rotary shadowing of intact and fragmented molecules. Biochemical Journal 1984 224 1 331 333 2-s2.0-0021702051 (Pubitemid 15189017)
59. Paulsson M., Mörgelin M., Wiedemann H., Beardmore-Gray M., Dunham D., Hardingham T., Heinegård D., Timpl R., Engel J., Extended and globular protein domains in cartilage proteoglycans. Biochemical Journal 1987 245 3 763 772 2-s2.0-0023393878
60. Watanabe H., Cheung S. C., Itano N., Kimata K., Yamada Y., Identification of hyaluronan-binding domains of aggrecan. The Journal of Biological Chemistry 1997 272 44 28057 28065 (Pubitemid 27473614)
61. Yamada H., Watanabe K., Shimonaka M., Yamaguchi Y., Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. The Journal of Biological Chemistry 1994 269 13 10119 10126 2-s2.0-0028233391 (Pubitemid 24196631)
62. Saleque S., Ruiz N., Drickamer K., Expression and characterization of a carbohydrate-binding fragment of rat aggrecan. Glycobiology 1993 3 2 185 190 2-s2.0-0027302341 (Pubitemid 23132609)
63. Miura R., Aspberg A., Ethell I. M., Hagihara K., Schnaar R. L., Ruoslahti E., Yamaguchi Y., The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. The Journal of Biological Chemistry 1999 274 16 11431 11438 2-s2.0-0033574427 10.1074/jbc.274.16.11431 (Pubitemid 29191142)
64. Theocharis A. D., Versican in health and disease. Connective Tissue Research 2008 49 3-4 230 234 2-s2.0-48549085400 10.1080/03008200802147571
65. Matsumoto K., Shionyu M., Go M., Shimizu K., Shinomura T., Kimata K., Watanabe H., Distinct interaction of versican/PG-M with hyaluronan and link protein. The Journal of Biological Chemistry 2003 278 42 41205 41212 2-s2.0-0142039864 10.1074/jbc.M305060200 (Pubitemid 37280947)
66. Yee A. J. M., Akens M., Yang B. L., Finkelstein J., Zheng P.-S., Deng Z., Yang B., The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Research 2007 9 4, article R42 2-s2.0-36549069171 10.1186/bcr1742
67. Siebert J. R., Osterhout D. J., The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. Journal of Neurochemistry 2011 119 1 176 188 2-s2.0-80052677773 10.1111/j.1471-4159.2011.07370.x
68. Jager C., Lendvai D., Seeger G., Bruckner G., Matthews R. T., Arendt T., Alpar A., Morawski M., Perineuronal and perisynaptic extracellular matrix in the human spinal cord. Neuroscience 2013 238 168 184
69. Tauchi R., Imagama S., Natori T., Ohgomori T., Muramoto A., Shinjo R., Matsuyama Y., Ishiguro N., Kadomatsu K., The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. Journal of Neuroinflammation 2012 9, article 53 2-s2.0-84858142863 10.1186/1742-2094-9- 53
70. Schultz C. C., Mühleisen T. W., Nenadic I., Koch K., Wagner G., Schachtzabel C., Siedek F., Nothen M. M., Rietschel M., Deufel T., Kiehntopf M., Cichon S., Reichenbach J. R., Sauer H., Schlosser R. G., Common variation in NCAN, a risk factor for bipolar disorder and schizophrenia, influences local cortical folding in schizophrenia. Psychological Medicine 2014 44 4 811 820
71. Miro X., Meier S., Dreisow M. L., Frank J., Strohmaier J., Breuer R., Schmal C., Albayram O., Pardo-Olmedilla M. T., Muhleisen T. W., Degenhardt F. A., Mattheisen M., Reinhard I., Bilkei-Gorzo A., Cichon S., Seidenbecher C., Rietschel M., Nothen M. M., Zimmer A., Studies in humans and mice implicate neurocan in the etiology of mania. American Journal of Psychiatry 2012 169 9 982 990
72. Schimmelmann B. G., Hinney A., Scherag A., Bipolar disorder risk alleles in children with ADHD. Journal of Neural Transmission 2013 120 11 1611 1617
73. Craddock N., Sklar P., Genetics of bipolar disorder. The Lancet 2013 381 9878 1654 1662
74. Lee K. W., Woon P. S., Teo Y. Y., Sim K., Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neuroscience and Biobehavioral Reviews 2012 36 1 556 571 2-s2.0-82855172104 10.1016/j.neubiorev.2011.09.001
75. Van Snellenberg J. X., De Candia T., Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Archives of General Psychiatry 2009 66 7 748 755 2-s2.0-67650456775 10.1001/archgenpsychiatry.2009. 64
76. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011 43 10 969 976
77. Avram S., Duda-Seiman D., Borcan F., Wolschann P., QSAR-CoMSIA applied to antipsychotic drugs with their dopamine D2 and serotonine 5HT2A membrane receptors. Journal of the Serbian Chemical Society 2011 76 2 263 281 2-s2.0-79952380186 10.2298/JSC100806022A
78. Lundell A., Olin A. I., Mörgelin M., Al-Karadaghi S., Aspberg A., Logan D. T., Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure 2004 12 8 1495 1506 2-s2.0-4143100146 10.1016/j.str.2004.05.021 (Pubitemid 39092094)
79. Avram S., Duda-Seiman D., Borcan F., Radu B., Duda-Seiman C., Mihailescu D., Evaluation of antimicrobial activity of new mastoparan derivatives using QSAR and computational mutagenesis. International Journal of Peptide Research and Therapeutics 2011 17 1 7 17 2-s2.0-79954437730 10.1007/s10989-010-9235-7
80. Calborean O., Mernea M., Avram S., Mihailescu D. F., Pharmacological descriptors related to the binding of Gp120 to CD4 corresponding to 60 representative HIV-1 strains. Journal of Enzyme Inhibition and Medicinal Chemistry 2013 28 5 1015 1025
81. Bhat S., Purisima E. O., Molecular surface generation using a variable-radius solvent probe. Proteins: Structure, Function and Genetics 2006 62 1 244 261 2-s2.0-30344480798 10.1002/prot.20682 (Pubitemid 43063022)
82. Li A. J., Nussinov R., A set of van der Waals and coulombic radii of protein atoms for molecular and solvent-accessible surface calculation, packing evaluation, and docking. Proteins 1998 32 1 111 127 (Pubitemid 28313257)
83. Oprea T. I., Property distribution of drug-related chemical databases. Journal of Computer-Aided Molecular Design 2000 14 3 251 264 2-s2.0-0034073605 10.1023/A:1008130001697 (Pubitemid 30175944)
84. Johnstone A. L., Reierson G. W., Smith R. P., Goldberg J. L., Lemmon V. P., Bixby J. L., A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates. Molecular and Cellular Neuroscience 2012 50 2 125 135
85. Avram S., Berner H., Milac A. L., Wolschann P., Quantitative structure-activity relationship studies on membrane receptors inhibition by antipsychotic drugs. Application to schizophrenia treatment. Monatshefte für Chemie 2008 139 4 407 426 2-s2.0-43349090657 10.1007/s00706-007-0782-3
86. Carpenter W. T. Jr., The deficit syndrome. American Journal of Psychiatry 1994 151 3 327 329 2-s2.0-0028218173 (Pubitemid 24081448)
87. Vahia I. V., Lanouette N. M., Golshan S., Fellows I., Mohamed S., Kasckow J. W., Zisook S., Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: impact on positive and negative symptoms. Indian Journal of Psychiatry 2013 55 2 144 148
88. Avram S., Milac A.-L., Mihailescu D., 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A. Molecular BioSystems 2012 8 5 1418 1425 2-s2.0-84859845863 10.1039/c2mb00005a
89. Lu X.-H., Dwyer D. S., Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. Journal of Molecular Neuroscience 2005 27 1 43 64 2-s2.0-23444439797 10.1385/JMN:27:01:43 (Pubitemid 41112378)
90. Donohoe D. R., Weeks K., Aamodt E. J., Dwyer D. S., Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans. International Journal of Developmental Neuroscience 2008 26 3-4 371 380 2-s2.0-41649112915 10.1016/j.ijdevneu.2007.08. 021
91. Zalesky A., Fornito A., Seal M. L., Cocchi L., Westin C.-F., Bullmore E. T., Egan G. F., Pantelis C., Disrupted axonal fiber connectivity in schizophrenia. Biological Psychiatry 2011 69 1 80 89 2-s2.0-78650031397 10.1016/j.biopsych.2010.08.022
92. Pantazopoulos H., Woo T.-U. W., Lim M. P., Lange N., Berretta S., Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Archives of General Psychiatry 2010 67 2 155 166 2-s2.0-76149138048 10.1001/archgenpsychiatry.2009.196
93. Yamaguchi Y., Lecticans: organizers of the brain extracellular matrix. Cellular and Molecular Life Sciences 2000 57 2 276 289 2-s2.0-0034024027 (Pubitemid 30311415)